Merck Lobbying Spend Actually Decreased Slightly, In Q1 2013, Compared To Q1 2012

MRK-Q1-13 While it has generally been true that Merck spends more in the middle of the year, on lobbying, than it does in the first quarter, in the past few years — this could be a sign that Merck will spend less than $10 million in all of 2013, on lobbying and lobbyists.

We will have to wait and see — but these are the preliminary Q1 2013 figures, and Merck’s spend is just about $300,000 lighter than it was in Q1 2012. Do recall though, that in Q1 2012, we did not yet know whether the ACA of 2010 — or “Obamacare” — would pass constitutional muster, so there was a lot of scurrying going on, to handle the what-if scenarios. That is all over — now it is all about implementation of Obamacare — in ways that best benefit Merck.

Here are the specific items Merck lobbied on or about, per its public filing for the quarter:

. . . .▲ Patent settlements (no specific bill).

Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (S. 351, H.R. 351).

▲ Alzheimer’s education (no specific bill); 340b (no specific bill); hepatitis C education (no specific bill).

▲ Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill); tax base erosion (no specific bill).

Trans-Pacific Partnership (no specific bill); biologic data exclusivity (no specific bill); US-EU trade agreement (no specific bill); trade promotion authority (no specific bill).

▲ Supply chain safety (no specific bills).

▲ Access to over-the-counter medications (no specific bill); compounding (no specific bill).

▲ Deficit reduction (no specific bill); ADAP funding (no specific bill).

▲ Animal Drug User Fee Act (ADUFA). . . .

There you have it — the lobbying against limits on drug patent “pay for delay” is particularly interesting, in my opinion.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s